Literature DB >> 35357439

Distinct Dimensions of Depression Are Associated With Different Brain-Related Biomarkers.

Laili Soleimani1, Michal Schnaider Beeri1,2, Anthony Heymann3,4, Abigail Livny2,3,5, Orit Lesman-Segev5, Hung-Mo Lin6, Yuxia Ouyang6, Ramit Ravona-Springer2,3,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35357439      PMCID： PMC9174967          DOI： 10.2337/dc21-1792

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   17.152


× No keyword cloud information.
  5 in total

1.  Confirmatory factor analysis of the geriatric depression scale.

Authors:  Kathryn Betts Adams; Holly C Matto; Sara Sanders
Journal:  Gerontologist       Date:  2004-12

2.  Long-term Variability in Glycemic Control Is Associated With White Matter Hyperintensities in APOE4 Genotype Carriers With Type 2 Diabetes.

Authors:  Abigail Livny; Ramit Ravona-Springer; Anthony Heymann; Rachel Priess; Tammar Kushnir; Galia Tsarfaty; Leeron Rabinov; Reut Moran; Hadass Hoffman; Itzik Cooper; Lior Greenbaum; Jeremy Silverman; Mary Sano; Sterling C Johnson; Barbara B Bendlin; Michal Schnaider Beeri
Journal:  Diabetes Care       Date:  2016-04-08       Impact factor: 19.112

3.  Specific Dimensions of Depression Have Different Associations With Cognitive Decline in Older Adults With Type 2 Diabetes.

Authors:  Laili Soleimani; Ramit Ravona-Springer; Hung-Mo Lin; Xiaoyu Liu; Mary Sano; Anthony Heymann; Michal Schnaider Beeri
Journal:  Diabetes Care       Date:  2021-01-19       Impact factor: 19.112

4.  Causal Impact of Type 2 Diabetes Mellitus on Cerebral Small Vessel Disease: A Mendelian Randomization Analysis.

Authors:  Junfeng Liu; Loes Rutten-Jacobs; Ming Liu; Hugh S Markus; Matthew Traylor
Journal:  Stroke       Date:  2018-04-23       Impact factor: 7.914

5.  Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression.

Authors:  B S Diniz; E Sibille; Y Ding; G Tseng; H J Aizenstein; F Lotrich; J T Becker; O L Lopez; M T Lotze; W E Klunk; C F Reynolds; M A Butters
Journal:  Mol Psychiatry       Date:  2014-08-05       Impact factor: 15.992
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.